Bioavailability Study of Cretan Carob

Launched by HAROKOPIO UNIVERSITY · May 12, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how well the body absorbs certain healthy compounds found in a drink made from Cretan carob powder, specifically from a variety called Imera. The researchers want to see how these compounds behave in healthy men after they consume the beverage. This study is currently looking for participants who are male, between the ages of 65 and 74, and have normal body fat.

To join the study, potential participants should be healthy and not have conditions like obesity, diabetes, heart disease, or any significant liver or kidney problems. They also should not be taking supplements for weight loss or be dietitians/nutritionists. If eligible, participants can expect to drink the carob beverage and provide feedback on their experience. This study aims to better understand the health benefits of carob and how it can fit into a healthy diet.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • healthy male adults
• • normal body fat mass
• Exclusion Criteria:
• • obesity (according to body fat mass)
• • Type 1 Diabetes, cardiovascular diseases, hypertension
• • thyroid disorder, liver disease, kidney disease
• • gastrointestinal disease
• • mental illness
• • use of nutraceutical supplements or natural products for weight loss
• • dietitians/nutritionists